Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs

被引:410
作者
Gershanik, T
Benita, S
机构
[1] Hebrew Univ Jerusalem, David R Bloom Ctr Pharm, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel
关键词
self-emulsifying; emulsion; microemulsion; dispersion; oral bioavailability; lipophilic drugs; positive charge;
D O I
10.1016/S0939-6411(00)00089-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main purpose of this review is to provide a current and general overview of the existing self-dispersing formulations resulting from dilution into emulsions, microemulsions and surfactant dispersions. The systematic approach used and the presentation of the Various physico-chemical and biopharmaceutical aspects should facilitate the comprehension of this interesting field and clarify the main considerations involved in designing and characterizing a specific self-dispersing drug delivery system. Studies have shown that the self-emulsification process is specific to the nature of the oil/surfactant pair, surfactant concentration, oil/surfactant ratio and temperature at which self-emulsification occurs. It was suggested that the ease of emulsification could be associated with the ease by which water penetrates into the various liquid crystalline (LC) or gel phases formed on the surface of the droplet. Numerous bioavailability studies carried out in animals and humans, reviewed in the present study, suggest that hydrophobic drugs are better absorbed when administered in self-dispersing lipid formulations (SDLFs). Examples which illustrate the beneficial use of SDLFs for drug absorption enhancement are presented. This review outlines SDLFs as one of the most promising approaches to overcome the formulation difficulties of these hydrophobic/lipophilic drugs. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 63 条
  • [21] The effect of a drug-delivery system consisting of soybean phosphatidyl choline and medium-chain monoacylglycerol on the intestinal permeability of hexarelin in the rat
    Fagerholm, U
    Sjöström, B
    Sroka-Markovic, J
    Wijk, A
    Svensson, M
    Lennernäs, H
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (05) : 467 - 473
  • [22] Farah N., 1994, Pharmaceutical Research (New York), V11, pS202
  • [23] Phase I/II study of the toxicity, pharmacokinetics, and activity of the HIV protease inhibitor SC-52151
    Fischl, MA
    Richman, DD
    Flexner, C
    Para, MF
    Haubrich, R
    Karim, A
    Yeramian, P
    HoldenWiltse, J
    Meehan, PM
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 15 (01): : 28 - 34
  • [24] The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual
    Florence, AT
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (03) : 259 - 266
  • [25] Georgakopoulos E, 1992, B T GATTEFOSSE, V85, P11
  • [26] Gershanik T, 1996, Pharm Dev Technol, V1, P147, DOI 10.3109/10837459609029889
  • [27] Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge
    Gershanik, T
    Benzeno, S
    Benita, S
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (06) : 863 - 869
  • [28] GERSHANIK T, 2000, UNPUB CHARGE DEPENDE
  • [29] PHARMACOKINETICS OF ORAL CYCLOSPORINE-A (SANDIMMUN) IN HEALTHY-SUBJECTS
    GREVEL, J
    NUESCH, E
    ABISCH, E
    KUTZ, K
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) : 211 - 216
  • [30] PHASE STUDIES OF MIXED PHOSPHATED SURFACTANTS, NORMAL-HEXANE AND WATER
    GROVES, MJ
    MUSTAFA, RMA
    CARLESS, JE
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (08) : 616 - 623